"The weight loss alone just didn't account for the magnitude of the observed effect," McDonald says
BPC-157: Mechanisms, Dosing Protocols, and Quality Considerations for Research Use 2026, Bergdorf Bioscience Technical Reports Abstract BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a naturally occurring protective protein in human gastric juice
Harvell D, Jordn-Dahlgren E, Merkel S, Rosenberg E, Raymundo L, Smith G, Weil E, Willis B (2007) Coral disease, environmental drivers, and the balance between coral and microbial associates
& Lynch, R
A 2024 survey found that around 12% of adults in the US have used a GLP-1 agonist drug, with 6% currently taking the drug
Retatrutides nausea rate of 28% at the 12 mg dose is substantially lower than Semaglutides 44% at 2.4 mg